{
  "id": "5141bcd423fec9037500000d",
  "type": "list",
  "question": "The CXCR2 receptor is targeted in cancer. Name five antagonists.",
  "ideal_answer": "There are numerous CXCR2 receptor antagonists, such as SB225002, G31P, SCH-527123, AZ10397767, SCH-479833.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/15623601",
    "http://www.ncbi.nlm.nih.gov/pubmed/19549892",
    "http://www.ncbi.nlm.nih.gov/pubmed/15805273",
    "http://www.ncbi.nlm.nih.gov/pubmed/22590561",
    "http://www.ncbi.nlm.nih.gov/pubmed/21328342",
    "http://www.ncbi.nlm.nih.gov/pubmed/19809428",
    "http://www.ncbi.nlm.nih.gov/pubmed/17634442",
    "http://www.ncbi.nlm.nih.gov/pubmed/18289803",
    "http://www.ncbi.nlm.nih.gov/pubmed/20967859",
    "http://www.ncbi.nlm.nih.gov/pubmed/23204236",
    "http://www.ncbi.nlm.nih.gov/pubmed/11700073",
    "http://www.ncbi.nlm.nih.gov/pubmed/20652010",
    "http://www.ncbi.nlm.nih.gov/pubmed/23019013",
    "http://www.ncbi.nlm.nih.gov/pubmed/16540656",
    "http://www.ncbi.nlm.nih.gov/pubmed/21670971",
    "http://www.ncbi.nlm.nih.gov/pubmed/18790747",
    "http://www.ncbi.nlm.nih.gov/pubmed/18780829",
    "http://www.ncbi.nlm.nih.gov/pubmed/22391039",
    "http://www.ncbi.nlm.nih.gov/pubmed/23359652",
    "http://www.ncbi.nlm.nih.gov/pubmed/12244149",
    "http://www.ncbi.nlm.nih.gov/pubmed/12753603",
    "http://www.ncbi.nlm.nih.gov/pubmed/19293256",
    "http://www.ncbi.nlm.nih.gov/pubmed/21035946"
  ],
  "snippets": [
    {
      "text": "CXCR2 small-molecule antagonist (SB225002)",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23204236",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/23019013",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "The CXCR2 antagonist, SCH-527123, shows antitumor activity",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22391039",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "retreatment with the CXCR2 antagonist AZ10397767",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/18790747",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "The aim of this study was to investigate whether the CXCR2 antagonist, SCH-527123, inhibits colorectal cancer proliferation and if it can sensitize colorectal cancer cells to oxaliplatin both in vitro and in vivo.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22391039",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "we report that targeting CXCR2 and CXCR1 activity using orally active small molecule antagonist (SCH-527123, SCH-479833) inhibits human colon cancer liver metastasis mediated by decreased neovascularization and enhanced malignant cell apoptosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21035946",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    },
    {
      "text": "CXCR2-specific small molecule inhibitor (AZ10397767) to investigate the recruitment and function of human neutrophils in tumors",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21328342",
      "beginSection": "sections.0",
      "endSection": "sections.0"
    }
  ],
  "concepts": [
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0048019",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0006605",
    "http://www.uniprot.org/uniprot/CXCR2_HUMAN",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0045238",
    "http://amigo.geneontology.org/cgi-bin/amigo/term_details?term=0046817",
    "http://www.disease-ontology.org/api/metadata/DOID:162"
  ],
  "exact_answer": "SB225002, G31P, SCH-527123, AZ10397767, SCH-479833"
}